The resultant metabolites of arachidonic acid by the rate-limiting enzyme COX2, that also serves as a direct target of Nrf2 [57,58], are much likely to play a crucial role in development and progression of inflammation, particularly NASH and hepatoma caused by knockout of Nrf1α−/−. Here, NFE2L2 is linked to metabolic dysfunction-associated steatohepatitis.